The uncharted role of HER2 mutant alleles in breast cancer
“Our research study has demonstrated that poziotinib is highly potent in neratinib-resistant HER2 L755S lobular and ductal breast cancer models ...
Tag: HER2
Oncoscience | A case for routine evaluation of HER2 expression in ductal carcinoma in situ
“We call upon the oncology community to embrace these results to avoid overtreatment of DCIS patients.” Credit: Nidhi Garg and ...
Next-generation SERD camizestrant significantly improves progression-free survival vs. fulvestrant in advanced ER+ HER2- breast cancer
Credit: Vall d'Hebron Institute of Oncology (VHIO). Presented at the 45th annual San Antonio Breast Cancer Symposium® (2022 SABCS®), ...
A potentially more effective treatment for HER2 mutant metastatic breast cancer
Breast cancers with HER2 mutations respond to the drug neratinib, but the responses are variable and often not durable. Looking ...
-
Meteorites likely source of nitrogen for early Earth
-
New implants linked to less infection and better recovery from orthopedic surgery
-
New theory unites Einstein’s gravity with quantum mechanics
-
‘Shocking’ discovery: Electricity from electric eels may transfer genetic material to nearby animals
-
Why have so many new diseases developed in the bagged salads sector?
-
New study identifies the greatest threat to wildlife across North America and Canada: people